Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LPCN

Lipocine Inc

May 06 • 04:00PM ET

2.43

+0.10 4.29 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: AXSM CORT DVAX ENTA ANIP EOLS ARDX MNKD

| Held by: VTI VXF DFAS DFMC DFAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.77	Insider Own	5.10%	Shs Outstand	8.03M	Perf Week	6.11%
Market Cap	19.50M	Forward P/E	-	EPS next Y	-1.65	Insider Trans	108.50%	Shs Float	7.62M	Perf Month	21.50%
Enterprise Value	4.57M	PEG	-	EPS next Q	-0.48	Inst Own	23.64%	Short Float	2.02%	Perf Quarter	-70.29%
Income	-9.63M	P/S	9.85	EPS this Y	-14.20%	Inst Trans	11.71%	Short Ratio	0.38	Perf Half Y	-8.30%
Sales	1.98M	P/B	1.03	EPS next Y	14.51%	ROA	-48.73%	Short Interest	0.15M	Perf YTD	-69.74%
Book/sh	2.35	P/C	1.31	EPS next 5Y	17.47%	ROE	-54.28%	52W High	12.37 -80.36%	Perf Year	-26.77%
Cash/sh	1.86	P/FCF	-	EPS past 3/5Y	5.11% 22.70%	ROIC	-66.50%	52W Low	1.81 34.25%	Perf 3Y	-41.18%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	58.12% -	Gross Margin	96.93%	Volatility	4.78% 7.25%	Perf 5Y	-89.49%
Dividend TTM	-	EV/Sales	2.31	EPS Y/Y TTM	-34713.73%	Oper. Margin	-524.69%	ATR (14)	0.34	Perf 10Y	-98.40%
Dividend Ex-Date	-	Quick Ratio	6.68	Sales Y/Y TTM	-82.35%	Profit Margin	-487.06%	RSI (14)	33.85	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.68	EPS Q/Q	-224.79%	SMA20	2.81%	Beta	0.50	Target Price	10.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-67.19%	SMA50	-54.22%	Rel Volume	0.39	Prev Close	2.33
Employees	14	LT Debt/Eq	0.00	Earnings	Mar 10 BMO	SMA200	-49.45%	Avg Volume	407.68K	Price	2.43
IPO	Jun 15, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	31.15% 867.84%	Trades		Volume	157,965	Change	4.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)